Skip to main content
. 2019 Dec 18;21(1):17. doi: 10.3390/ijms21010017

Table 1.

Baseline characteristics between patients with recurrent pregnancy loss (RPL) and controls.

Characteristic Controls (n = 384) RPL Patients (n = 412) p a
Age (years, mean ± SD) 32.84 ± 4.17 33.09 ± 4.30 0.4224
BMI (kg/m2) 21.78 ± 3.29 21.48 ± 3.87 0.459 b
Live birth (n, mean ± SD) 1.64 ± 0.57 -
Pregnancy loss (n, mean ± SD) - 3.27 ± 1.83
Gestational age at the termination of previous pregnancy (week, mean ± SD) 39.21 ± 1.66 7.41 ± 1.89
IVF treatment (n, pregnancy loss n (mean ± SD)
- Nontreatment - 334 (3.38 ± 1.98)
- One cycle - 33 (2.65 ± 1.29)
- Two cycles - 41 (3.18 ± 1.22)
- Three cycles - 3 (3.50 ± 1.29)
Hematocrit (μmol/L) 35.76 ± 4.10 37.25 ± 3.69 0.0001
PLT (103/µL) 237.61 ± 61.07 255.37 ± 59.05 0.003
PT (sec) 11.52 ± 3.36 11.32 ± 1.76 0.0001 b
aPTT (sec) 29.92 ± 4.24 32.02 ± 4.25 0.0001
BUN (mg/dL) 8.03 ± 2.01 9.95 ± 2.69 <0.0001 b
Creatinine (mg/dL) 0.69 ± 0.08 0.73 ± 0.13 0.025 b
Uric acid (mg/dL) 4.19 ± 1.44 3.80 ± 0.82 0.340 b
Total cholesterol (mg/dl) 239.00 ± 85.19 187.70 ± 49.06 0.004 b
Folate (nmol/L) 13.71 ± 8.37 16.94 ± 19.70 0.887 b
Homocysteine (μmol/L) 7.28 ± 1.58 6.91 ± 2.06 0.536
FSH (mIU/mL) 8.12 ± 2.85 7.76 ± 11.47 <0.0001 b
LH (mIU/mL) 3.26 ± 1.76 6.37 ± 11.95 <0.0001 b
E2 (pg/mL) 26.00 ± 14.75 43.55 ± 72.70 0.0002 b
TSH (µIU/mL) - 2.16 ± 1.52 -
Prolactin (ng/mL) - 15.35 ± 12.76 -
Triglyceride (mg/dL) - 181.42 ± 156.63 -
HDL cholesterol (mg/dL) - 61.82 ± 17.63 -
FBS (mg/dL) - 95.05 ± 16.87 -

a Two-sided t-test. b Mann–Whitney test. BMI, body mass index; IVF, in-vitro fertilization; PLT, platelet; PT, prothrombin time; aPTT, activated partial thromboplastin time; BMI, body mass index; BUN, blood urea nitrogen; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; TSH, thyroid-stimulating hormone; HDL cholesterol, high-density lipoprotein cholesterol; FBS, fasting blood sugar; SD, standard deviation.